Lichen Capital

elsewhere's corpus does not cover Lichen Capital as a subject in its own right. The only references to it are as a co-investor in two deals: it followed on in Zhitai Bio's round alongside BlueRun Ventures and others , and it followed on and then re-upped in Bivision Pharmaceuticals' angel and Series A rounds led by Gaorong Ventures . No founding date, team, strategy, or fund size is stated in the retrieved material.